A veteran entertainment executive and investor known for deep film and rights expertise, Christopher Plummer transitioned industry knowledge into strategic media and content investments, focusing on production companies, IP monetization and boutique theatrical distribution. Serves as active advisor and board participant for creative enterprises, leveraging long-standing industry relationships to source private deals and co-investments. Investment style emphasizes legacy content, catalog acquisition and selective early-stage media technology opportunities.
A veteran entertainment executive and investor known for deep film and rights expertise, Christopher Plummer transitioned industry knowledge into strategic media and content investments, focusing on production companies, IP monetization and boutique theatrical distribution. Serves as active advisor and board participant for creative enterprises, leveraging long-standing industry relationships to source private deals and co-investments. Investment style emphasizes legacy content, catalog acquisition and selective early-stage media technology opportunities.
Combines deep rights and production expertise to favor durable content assets and catalog acquisitions that generate predictable licensing and distribution cashflows. Allocates capital between acquiring legacy IP, minority stakes in production companies and selective early‑stage media technologies that amplify monetization. Investment decisions are relationship‑driven, underwritten for long horizons and structural value rather than short-term growth. Takes active board/advisory roles, syndicates co-investors, and prioritizes downside protection through rights control and diversified revenue streams.
Combines deep rights and production expertise to favor durable content assets and catalog acquisitions that generate predictable licensing and distribution cashflows. Allocates capital between acquiring legacy IP, minority stakes in production companies and selective early‑stage media technologies that amplify monetization. Investment decisions are relationship‑driven, underwritten for long horizons and structural value rather than short-term growth. Takes active board/advisory roles, syndicates co-investors, and prioritizes downside protection through rights control and diversified revenue streams.
| Trades 734 | Longs Won 435/734 59% | Profit Factor 4.29 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $292,441.48 |
| Average Win $117,996.91 | Best Trade (Aug 31) $4.52M | Sharpe Ratio -11.08 |
| Average Loss -$40,046.91 | Worst Trade (Sep 29) -$813,335.17 | Z-Score 5.06 (100%) |
| Commissions $0 | Avg. Trade Length 11m 3w 5d | Expectancy $53,616.66 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,348 | 4,813 | 4,278 | 3,743 | 3,209 | 2,674 | 2,139 | 1,604 | 1,070 | 535 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 53,989 | $12.58M | $16.79M | - | $4.21M | 33.43% | +0.524% |
ABBV AbbVie Inc. | 17,471 | $3.44M | $4.26M | - | $820,587.92 | 23.86% | 0.0 |
ABT Abbott Laboratories | 2,925 | $344,479.29 | $308,470.5 | - | -$36,008.79 | -10.45% | 0.0 |
AGG iShares Core U.S. Aggregate Bond ETF | 4,892 | $484,210 | $477,336.9 | - | -$6,873.1 | -1.42% | -0.087% |
AIG American International Group Inc. | 7,000 | $546,885 | $559,440 | - | $12,555 | 2.3% | +0.756% |
ALL Allstate Corporation | 2,058 | $491,903 | $540,348.48 | - | $48,445.48 | 9.85% | 0.0 |
AMD Advanced Micro Devices, Inc. | 1,000 | $580,910 | $518,580.02 | - | -$62,329.98 | -10.73% | 0.0 |
AMSC American Superconductor Corporation | 5,000 | $207,550 | $154,950 | - | -$52,600 | -25.34% | -7.354% |
AMZN Amazon.com Inc | 10,278 | $1.95M | $2.85M | - | $897,221.82 | 45.91% | 0.0 |
ARCC Ares Capital Corporation | 11,586 | $244,651.31 | $217,353.36 | - | -$27,297.95 | -11.16% | -4.529% |
AXP American Express Company | 3,973 | $1.08M | $1.38M | - | $299,196.78 | 27.75% | 0.0 |
BA Boeing Company | 7,105 | $1.3M | $1.69M | - | $389,125.24 | 30.03% | 0.0 |
BAC Bank of America Corporation | 10,495 | $438,696.4 | $663,808.75 | - | $225,112.35 | 51.31% | +0.556% |
BILS SPDR Bloomberg 3-12 Month T-Bill ETF | 131,967 | $13.11M | $13.09M | - | -$25,737.14 | -0.2% | +0.005% |
BLK BlackRock, Inc. | 517 | $529,981.78 | $584,794.21 | - | $54,812.43 | 10.34% | 0.0 |
BMY Bristol-Myers Squibb Company | 41,150 | $2.13M | $2.62M | - | $483,927.49 | 22.67% | -3.43% |
BNL Broadstone Net Lease Inc. | 155,720 | $2.92M | $3.33M | - | $415,029.63 | 14.22% | +1.181% |
BRK-B Berkshire Hathaway Inc. | 2,220 | $1.09M | $1.15M | - | $56,543.2 | 5.18% | 0.0 |
BX Blackstone Inc. | 2,320 | $354,605.29 | $318,304 | - | -$36,301.29 | -10.24% | 0.0 |
CAG Conagra Brands Inc. | 49,650 | $840,979 | $745,743 | - | -$95,236 | -11.32% | +0.133% |